HIV-1Subtype C Therapeutic Vaccine
This technology relates to the augmentation of HIV specific immune response by co-immunization with HIV-1 vaccinogens and immunomodulators like Immunostimulatory sequences which help the patient in combating and controlling the virus replication in them. The combination of vaccinogens and Immunomodulators are selected from CpG motifs and recombinant plasmids vaccine construct; Interleukin-2 and recombinant plasmids; CpG motifs, interleukin-2 and recombinant plasmids; CpG motifs and recombinant viral vector vaccine constructs; Interleukin-2 and recombinant viral vector vaccine constructs; CpG motifs, interleukin-2 and recombinant viral vector vaccine constructs.
Sector: Pharmaceuticals
Country: India
Area of Application: Therapeutic Vaccine,vulnerable
Keywords: Therapeutic Vaccine
Advantages: No resistance to the antiretroviral treatment Cost-effective Increases patient life span Not Toxic Huge market opportunity No side effects
Environmental aspects: Not Applicable
Development Status: Laboratory Model
Legal Protection: Patent
Technical specifications:
Transfer Terms: Technology Licensing
Target Countries: India
Estimated cost (US$):
Upload any relevant document:
Contact Person: SkyQuest Technology Consulting Pvt. Ltd.
Address: 501, Krishna Complex, Opp. Devashish School, Bodakdev
City: Ahmedabad
Country: India
Zip/Pin Code: 380054